Suprex Biotech Private Limited - Company Profile

It is a chemicals private limited company based in Ujjain, Madhya Pradesh, India, established in 2001.
2001 Ujjain, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Suprex Biotech Private Limited

Suprex Biotech Private Limited, a struck off private limited company, was established on 07 March 2001 in Ujjain, Madhya Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MP2001PTC014579. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.16 M.

Its leadership includes Urmil Chatrath (Director), Shakuntala Chopra (Director), Chandra Kumar Chatrath (Director). Its latest AGM occurred on 28 September 2012, with the balance sheet filed on 31 March 2012. It is based at 11, Tilak Marg Indore Gate, Ujjain, Madhya Pradesh, 456006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MP2001PTC014579

  • Registration Number

    014579

  • Incorporation Date

    07 March 2001

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.16 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.16 M
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2012
Company report

Suprex Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Suprex Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Suprex Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Urmil Chatrath Director 07 Mar 2001 Current
Shakuntala Chopra Director 07 Mar 2001 Current
Chandra Kumar Chatrath Director 07 Mar 2001 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Suprex Biotech.

Enhance accessibility to Suprex Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Suprex Biotech revenue growth over time
Suprex Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Suprex Biotech?

Unlock access to Suprex Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Suprex Biotech?

Unlock and access historical data on people associated with Suprex Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Suprex Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suprex Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Suprex Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Suprex Biotech Private Limited last Annual general meeting of members was held on 28 Sep 2012 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Suprex Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Gwalior. was completed.

  • Director Appointment

    Progress on Urmil Chatrath was appointed as a Director was appointed as a Director on 07 Mar 2001 & has been associated with this company since 24 years 11 months . was documented.

  • Director Appointment

    Shakuntala Chopra was appointed as a Director was appointed as a Director on 07 Mar 2001 & has been associated with this company since 24 years 11 months . was recorded as a recent event.

  • Director Appointment

    Chandra Kumar Chatrath was appointed as a Director was appointed as a Director on 07 Mar 2001 & has been associated with this company since 24 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Suprex Biotech Private Limited was registered on 07 Mar 2001 with Roc Gwalior & aged 24 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Suprex Biotech Private Limited?

The CIN of Suprex Biotech Private Limited is U24232MP2001PTC014579.

Where is Suprex Biotech Private Limited headquartered?

Suprex Biotech Private Limited is headquartered at 11, Tilak Marg Indore Gate, Ujjain, Madhya Pradesh, 456006.

When was Suprex Biotech Private Limited incorporated?

Suprex Biotech Private Limited was incorporated on 07 March 2001.

Who are the current directors of Suprex Biotech Private Limited?

The current directors of Suprex Biotech Private Limited are

What is the primary industry of Suprex Biotech Private Limited?

The primary industry of Suprex Biotech Private Limited is Chemicals.

Is Suprex Biotech Private Limited a listed company?

Suprex Biotech Private Limited is unlisted.

What is the capital structure of Suprex Biotech Private Limited?

The authorized capital of Suprex Biotech Private Limited is ₹0.20 M, and the paid-up capital is ₹0.16 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available